AKT: A Potential Target for Thyroid Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|4|3|181-185

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.3, 2004-09, pp. : 181-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Akt as a therapeutic target in cancer

By Steelman Linda S   Stadelman Kristin M   Chappell William H   Horn Stefan   Bäsecke Jörg   Cervello Melchiorre   Nicoletti Ferdinando   Libra Massimo   Stivala Franca   Martelli Alberto M   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1139-1165

Informa Healthcare

Access to resources Recommend Favorite

The centrosome as potential target for cancer therapy and prevention

By Korzeniewski Nina   Hohenfellner Markus   Duensing Stefan  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 43-52

Informa Healthcare

Access to resources Recommend Favorite

Par-4 as a potential target for cancer therapy

By Irby Rosalyn B   Kline Christina LB  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 77-87

Informa Healthcare

Access to resources Recommend Favorite

The Urokinase Receptor as a Potential Target in Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2359-2376

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Akt Pathway in Oncogenesis and as a Target for Anti-Cancer Therapy (Guest Editor: Jin Q. Cheng) ]

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite